Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-22-106850
Filing Date
2022-04-15
Accepted
2022-04-15 16:31:37
Documents
3
Period of Report
2022-06-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A d352067dpre14a.htm PRE 14A 550868
2 GRAPHIC g352067g01a11.jpg GRAPHIC 394728
3 GRAPHIC g352067g02s33.jpg GRAPHIC 229133
  Complete submission text file 0001193125-22-106850.txt   1410768
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33038 | Film No.: 22830334
SIC: 2834 Pharmaceutical Preparations